Seneca Therapeutics To Host a Key Opinion Leader Webinar on Seneca Valley Virus and TEM 8 On Wednesday, March 16th @ 2pmET
Seneca Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to the development of targeted oncolytic immunotherapeutics based on Seneca Valley Virus (SVV-001), announced today that it will host a key opinion leader (KOL) webinar titled Seneca Valley Virus and TEM8 on Wednesday, March 16, 2022 at 2:00pm Eastern Time.